Compare Stocks

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CVII Churchill Capital Corp VII	$10.75 +0.1%	$10.68	$10.16 ▼ $10.85	$984.27M	0.05	262,476 shs	3,777 shs
FTCV Fintech Acquisition Corp. V	$10.06	$10.06	$9.74 ▼ $10.10	$343.92M	0.17	171,415 shs	10 shs
HMCO HumanCo Acquisition	$10.06	$10.05	$9.73 ▼ $10.30	$386.69M	-0.05	81,457 shs	80,170 shs
RAAC Revolution Acceleration Acquisition	$1.40	$8.42	$8.50 ▼ $13.45	$53.67M	N/A	611,327 shs	156 shs
TSIA TS Innovation Acquisitions		$11.38	$9.86 ▼ $19.70	$29.25M	N/A	895,744 shs	19,185 shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CVII Churchill Capital Corp VII	+0.09%	+0.37%	+0.47%	+1.80%	+5.71%
FTCV Fintech Acquisition Corp. V	0.00%	0.00%	0.00%	0.00%	0.00%
HMCO HumanCo Acquisition	0.00%	0.00%	0.00%	0.00%	0.00%
RAAC Revolution Acceleration Acquisition	0.00%	0.00%	0.00%	0.00%	+1.45%
TSIA TS Innovation Acquisitions	0.00%	0.00%	-7.02%	-3.70%	+6.66%

The World's First "$20 Trillion Drug?" (Ad)

One small biotech holds the key to a revolution in treating Alzheimer's disease. Jeff Bezos, Goldman Sachs & Big Pharma giants have invested billions into this unknown biotech. Our research proves that anyone who gets in today could see gains as high as 113,000%!

Get the name of the stock here >>>

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CVII Churchill Capital Corp VII	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FTCV Fintech Acquisition Corp. V	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
HMCO HumanCo Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
RAAC Revolution Acceleration Acquisition	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TSIA TS Innovation Acquisitions	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CVII Churchill Capital Corp VII	N/A	N/A	N/A	N/A
FTCV Fintech Acquisition Corp. V	N/A	N/A	N/A	N/A
HMCO HumanCo Acquisition	N/A	N/A	N/A	N/A
RAAC Revolution Acceleration Acquisition	N/A	N/A	N/A	N/A
TSIA TS Innovation Acquisitions	N/A	N/A	N/A	N/A

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CVII Churchill Capital Corp VII	N/A	N/A	$0.48 per share	22.59	($1.24) per share	N/A
FTCV Fintech Acquisition Corp. V	N/A	N/A	$0.02 per share	628.73	($0.76) per share	N/A
HMCO HumanCo Acquisition	N/A	N/A	$0.30 per share	33.00	($0.08) per share	N/A
RAAC Revolution Acceleration Acquisition	N/A	N/A	N/A	N/A	$0.13 per share	N/A
TSIA TS Innovation Acquisitions	N/A	N/A	N/A	N/A	$0.13 per share	N/A

Profitability & Earnings

Company	Net Income	EPS	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CVII Churchill Capital Corp VII	$16.39M	N/A	∞	N/A	N/A	-27.40%	2.02%	N/A
FTCV Fintech Acquisition Corp. V	$550K	N/A	∞	N/A	N/A	-89.81%	6.83%	N/A
HMCO HumanCo Acquisition	$11.72M	N/A	∞	N/A	N/A	-84.80%	4.37%	N/A
RAAC Revolution Acceleration Acquisition	-$1.65M	N/A	∞	N/A	N/A	N/A	N/A	N/A
TSIA TS Innovation Acquisitions	-$7.39M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CVII Churchill Capital Corp VII	N/A	N/A	N/A	N/A	N/A
FTCV Fintech Acquisition Corp. V	N/A	N/A	N/A	N/A	N/A
HMCO HumanCo Acquisition	N/A	N/A	N/A	N/A	N/A
RAAC Revolution Acceleration Acquisition	N/A	N/A	N/A	N/A	N/A
TSIA TS Innovation Acquisitions	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CVII Churchill Capital Corp VII	N/A	0.23	0.23
FTCV Fintech Acquisition Corp. V	N/A	0.06	0.06
HMCO HumanCo Acquisition	N/A	0.65	0.65
RAAC Revolution Acceleration Acquisition	N/A	0.26	0.26
TSIA TS Innovation Acquisitions	N/A	0.41	0.41

Ownership

Institutional Ownership

Company	Institutional Ownership
CVII Churchill Capital Corp VII	61.16%
FTCV Fintech Acquisition Corp. V	64.70%
HMCO HumanCo Acquisition	55.26%
RAAC Revolution Acceleration Acquisition	52.56%
TSIA TS Innovation Acquisitions	40.03%

Insider Ownership

Company	Insider Ownership
CVII Churchill Capital Corp VII	37.30%
FTCV Fintech Acquisition Corp. V	N/A
HMCO HumanCo Acquisition	7.02%
RAAC Revolution Acceleration Acquisition	N/A
TSIA TS Innovation Acquisitions	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CVII Churchill Capital Corp VII	2	91.56 million	57.41 million	Optionable
FTCV Fintech Acquisition Corp. V	3	34.19 million	N/A	Not Optionable
HMCO HumanCo Acquisition	4	38.44 million	35.74 million	Not Optionable
RAAC Revolution Acceleration Acquisition	N/A	38.33 million	N/A	Not Optionable
TSIA TS Innovation Acquisitions	N/A	37.50 million	N/A	Not Optionable

TSIA, HMCO, RAAC, FTCV, and CVII Headlines

Source	Headline
	computerworld computerworld.com - February 23 at 6:13 PM
	RBC I&TS rebrands following CACEIS acquisition assetservicingtimes.com - August 4 at 5:03 PM
	Innovation on my mind; innovation in my business scmr.com - January 25 at 12:45 PM
	LATCH ALERT: Bragar Eagel & Squire, P.C. is Investigating Latch, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm benzinga.com - January 13 at 11:29 PM
	Latch Investors Who Held TS Innovation Acquisitions Corp. Stock Encouraged to Contact Kehoe Law Firm, P.C. - Breach of Fiduciary Duties Investigation benzinga.com - October 14 at 3:16 PM
	LTCH LAWSUIT ALERT: Levi & Korsinsky Notifies Latch, Inc. f/k/a TS Innovation Acquisitions Corp. Investors of a Class Action Lawsuit and Upcoming Deadline prnewswire.com - September 22 at 6:11 AM
	LTCH ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of October 31, 2022 in the Class Action Filed on Behalf of Latch, Inc. f/k/a TS Innovation Acquisitions Corp. Shareholders prnewswire.com - September 20 at 6:13 AM
	AZRE, ABT & LTCH Class Action Reminders: Bronstein, Gewirtz & Grossman, LLC, A Top Class Action Firm, Reminds Investors to Actively Participate benzinga.com - September 16 at 10:10 PM
	EV Technology Group Announces Definitive Agreement to Acquire Portfolio of Iconic Automotive Brands of Ford, Maserati and Ferrari Coach Builders technews.tmcnet.com - September 16 at 11:49 AM
	Latch Investor Alert stockhouse.com - August 31 at 9:39 PM
	Latch Reports Second Quarter 2021 Financial Results stockhouse.com - August 12 at 4:39 PM

Media Sentiment Over Time

Company Descriptions

Churchill Capital Corp VII

NYSE:CVII

Churchill Capital Corp VII, a blank check company, focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.

Fintech Acquisition Corp. V

NASDAQ:FTCV

Fintech Acquisition Corp. V does not have significant operations. It intends to focus on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination, with one or more businesses in the financial technology industry. The company was incorporated in 2019 and is based in Philadelphia, Pennsylvania.

HumanCo Acquisition

NASDAQ:HMCO

HumanCo Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on investing in and building a company within the health and wellness ecosystem. The company was incorporated in 2020 and is based in Austin, Texas.

Revolution Acceleration Acquisition

NASDAQ:RAAC

Revolution Acceleration Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Acceleration Acquisition Corporation and changed its name to Revolution Acceleration Acquisition Corp in November 2020. Revolution Acceleration Acquisition Corp was incorporated in 2020 and is based in Washington, District of Columbia.

TS Innovation Acquisitions

NASDAQ:TSIA

TS Innovation Acquisitions Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on identifying businesses in the real estate industry. The company was incorporated in 2020 and is based in New York, New York.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial